CN
CN
Our latest
Creative Biosciences
Lunsafe® Wins NMPA Approval, Pioneering Noninvasive Early Detection of Lung Cancer in China

Guangzhou, China – May 30, 2025 – Creative Biosciences (Guangzhou) CO., Ltd. today announced that its independently developed methylation test kit for the early detection of lung cancer, Lunsafe, has received official approval from China’s National Medic

Jun 01 , 2025
Media Coverage
Authoritative media releases


Read more
Press releases
Science and Technology Promotes Health, Innovation Shapes Future.Successful Topping Out Ceremony for Creative Biosciences’ New Headquarter Buildings
Dec 14 , 2023
Robust Performance of Colosafe®!Multicenter Clinical Study Published on Clinical Epigenetics
Nov 01 , 2020
Blockbuster! CreativeBio Completed the Rd C Financing of ￥600 million Laying a Solid Foundation to Be the Leader in Earl
Sep 30 , 2020
Adding Soaring Wings to the Tiger-CreativeBio Welcomes its New COO and VP(Public Health)
Sep 14 , 2020
Creative Biosciences Successfully Completed the Acquisition of Helixgen
Mar 31 , 2020
A Colorectal Cancer Screening Program Has Been Officially Launched by The Ministry of Science and Technology
Sep 18 , 2021

No. 10 Fenghuang Wu Road
Huangpu District
Guangzhou, Guangdong, 510555
P.R. China


Contact us at

T: +001-206-717-2769
Email: info@creativebio.cn


copyright ©2025 Creative Biosciences (Guangzhou) CO., Ltd
Legal mention